Atrium Therapeutics receives $15 million milestone from Bristol Myers Squibb
Go back to Atrium Therapeutics receives $15 million milestone from Bristol Myers Squibb| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 66.92 +0.11 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.81 | 52 Week High | $77.12 | |||
| Open | $67.58 | 52 Week Low | $49.03 | |||
| Day High | $68.04 | P/E | 43.45 | |||
| Day Low | $66.65 | EPS | $1.54 | |||
| Volume | 6,933,287 | |||||
| PROSENSA HOLD (NASDAQ: RNA) | Delayed: 13.77 +0.45 (3.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.32 | 52 Week High | $22.80 | |||
| Open | $13.24 | 52 Week Low | $4.12 | |||
| Day High | $13.92 | P/E | N/A | |||
| Day Low | $13.20 | EPS | $0.00 | |||
| Volume | 178,348 | |||||

